ENACCTION Newsletter May 2013

Spring | May 15, 2013
 

Establishing Core Competencies for "Clinical Trial Accrual Professionals"

What are the competencies and proficiencies necessary to accrue patients to clinical trials?

The Education Network to Advance Cancer Clinical Trials (ENACCT) is conducting a national survey to develop a new training program to improve the performance of those professionals who--as a core part of their job responsibilities--accrue patients to clinical trials. In previous surveys, these “Clinical Trials Accrual Professionals” identified a need to measure and recognize the competencies and proficiencies necessary to accrue patients to clinical trials—currently unrecognized in any national certification programs.

In our initial survey last May, over 43% of respondents indicated that this type of certification definitely or probably could help increase clinical trial participation in their community. Nearly 50% considered this valuable to them personally. The second survey, conducted last November, found that these Clinical Trials Accrual Professionals (CTAPs) are involved in wide range of activities (see Chart 1) along the clinical trial accrual continuum. While the role varied, this involvement was consistent across a variety of job categories from Clinical Research Nurse to Clinical Trials Coordinator to Clinical Trials Associate to Clinical Trials Assistant. 

Chart 1. Role in Clinical Trial Accrual

This survey also found that over 45% of CTAPs do not believe they have the all the necessary skills and knowledge to accrue patients and 86% are interested in training on best practices and innovative approaches to clinical trials accrual.

With the help of a panel of experts, ENACCT has organized nearly 150 accrual related activities into 17 core competencies in 7 domains, that are critical to all professionals working in the field.

ENACCT is now seeking assistance from professionals in the field to help refine these competencies and the skills, knowledge and abilities necessary to accrue patients to trials in the most effective manner.  ENACCT will use this information to refine existing courses and develop a comprehensive curriculum and Certificate program to fill the training gaps for Clinical Trials Accrual Professionals. If you would like participate in this survey, go to: http://tinyurl.com/c66hjq9  
 


 



Assessing Sites’ Accrual Practices: Useful Information for Community Oncology Practices and Cancer Centers 

In our article published in the May/June edition of Oncology Issues, we outline six dimensions of an effective clinical trials process, with a focus on efficient accrual practices. These dimensions and the associated questions are based on an extensive literature review, our Breakthrough Collaborative and our experience working with individual organizations with our 360° Clinical Trial Assessment and Improvement Protocol. Through this service, ENACCT conducts individual and group interviews with a cross section of leaders and staff in an affiliation with a research-based cancer center. Relevant data and documents are collected and analyzed in order to identify gaps and weaknesses in the clinical trials process and specific are recommended for improvement. 

       

In Fall 2013, ENACCT will launch our 360° Clinical Trial Self-Assessment Tool to help community cancer centers and networks evaluate and improve their own cancer clinical trials accrual using these same critical dimensions. The tool is designed as a guided analysis which can be completed online, ideally by the cancer research leadership team, with data provided by staff.These dimensions are based on ENACCT 360° Clinical Trial Assessment and Improvement Protocol in which ENACCT conducts individual and group interviews with a cross section of leaders and staff in an affiliation with a research-based cancer center. Relevant data and documents are collected and analyzed in order to identify gaps and weaknesses in the CT process and recommend strategies for improvement.

Designed to focus the attention of the leadership team on qualitative and quantitative factors across the critical dimensions of an effective clinical trials process, the tool will provide benchmarks to participation sites against their peers and the ideal. ENACCT will provide users with specific feedback on their strengths and weaknesses and provide additional technical assistance as needed to ameliorate barriers and capitalize on opportunities to improve accrual.

Check back frequently for more news about the launch of this exciting self-assessment tool in the fall of 2013!
 



Apply to join the Cancer Clinical Trials Collaborative Learning Network (CCTCLN) to Increase Clinical Trials Accrual

Currently Accepting Applications! Apply Today!

The CCTCLN is built upon the successful work of the National Pilot Collaborative completed in 2012. The goal of the CCTCLN is to further the goal of the Pilot: to identify practical, patient-centered approaches to increase accrual overall and, in particular, for ethnic/racial minorities and people over 65.

To learn more about this opportunity and to access the RFA materials, please visit the project website:
http://www.enacct.org/our-programs/national-cancer-clinical-trials-collaborative-learning-network-ncctcln